AQST
Aquestive Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.61
−1.07%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $11.0M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.18
- EPS estimate
- -$0.10
- Revenue actual
- $13.8M
- Revenue estimate
- $11.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -37.2%
- Revenue beats (12Q)
- 10
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.10 | -$0.18 | Miss -71.43% | $13.8M |
| May 14, 2026 | -$0.14 | -$0.07 | Beat 50.00% | $14.4M |
| Mar 5, 2026 | -$0.13 | -$0.26 | Miss -100.00% | $13.0M |
| Nov 5, 2025 | -$0.11 | -$0.14 | Miss -27.27% | $12.8M |
| Mar 5, 2025 | -$0.14 | -$0.19 | Miss -35.71% | $11.9M |
| Mar 5, 2024 | -$0.08 | -$0.12 | Miss -50.00% | $13.2M |
| May 2, 2023 | -$0.10 | $0.11 | Beat 210.00% | $11.1M |
| Mar 7, 2023 | -$0.21 | -$0.23 | Miss -9.52% | $10.7M |
| Nov 1, 2022 | -$0.30 | -$0.23 | Beat 23.33% | $11.5M |
| Aug 2, 2022 | -$0.41 | -$0.36 | Beat 12.20% | $13.3M |
| May 3, 2022 | -$0.45 | -$0.32 | Beat 28.89% | $12.3M |
| Mar 8, 2022 | -$0.37 | -$0.38 | Miss -2.70% | $11.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026